Cited by 54Metabolism and Genetic DisordersMitochondrial Function and PathologyMetabolomics and Mass Spectrometry Studies

Plasma metabolomics reveals a diagnostic metabolic fingerprint for mitochondrial aconitase (ACO2) deficiency

Open access
Abela, Lucia, Spiegel, Ronen, Crowther, Lisa M., Klein, Andrea, Steindl, Katharina, Papuc, Sorina Mihaela, Joset, Pascal, Zehavi, Yoav +3 more·2017·PLoS ONE

Abstract

Mitochondrial respiratory chain dysfunction has been identified in a number of neurodegenerative disorders. Infantile cerebellar-retinal degeneration associated with mutations in the mitochondrial aconitase 2 gene (ACO2) has been recently described as a neurodegenerative disease of autosomal recessive inheritance. To date there is no biomarker for ACO2 deficiency and diagnosis relies on genetic analysis. Here we report global metabolic profiling in eight patients with ACO2 deficiency. Using an LC-MS-based metabolomics platform we have identified several metabolites with affected plasma concentrations including the tricarboxylic acid cycle metabolites cis-aconitate, isocitrate and alpha-ketoglutarate, as well as phosphoenolpyruvate and hydroxybutyrate. Taken together we report a diagnostic metabolic fingerprint for mitochondrial aconitase 2 deficiency.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0176363

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Other studies involving rare diseases, difficult-to-access tissue, or smaller grants are characterized by similarly low sample sizes.

    “Other studies that involve rare diseases, the collection of difficult-to-access tissue, or smaller grants that do not allow for large consortium samples are characterized by similarly low sample sizes (Sirrs et al., 2015; Abela et al., 2017).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Abela, L., Spiegel, R., Crowther, L. M., Klein, A., Steindl, K., Papuc, S. M., Joset, P., Zehavi, Y., Rauch, A., Plecko, B., & Simmons, T. L.
Affiliations
  • University of Zurich (CH)
  • Technion – Israel Institute of Technology (IL)
  • University Children's Hospital Zurich (CH)
Corresponding author
Simmons, Thomas Luke
Venue
PLoS ONE
Published
2017-05-02
Volume
12
Issue
5
Pages
e0176363
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2611477370
Cited by
54
References
41
Citations by year
2026: 1 · 2025: 4 · 2024: 7 · 2023: 12 · 2022: 7 · 2021: 2 · 2020: 9 · 2019: 7 · 2018: 5
FWCI
4.77
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • Novartis Stiftung für Medizinisch-Biologische Forschung (15A039)
  • University of Zurich Clinical Research Priority Program, Rare Disease Initiative Zurich
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
Keywords
ACO2, plasma metabolomics, tricarboxylic acid cycle metabolites, cis-aconitate, isocitrate, alpha-ketoglutarate, phosphoenolpyruvate, hydroxybutyrate, mitochondrial respiratory chain dysfunction, neurodegenerative diseases, biomarkers
MeSH terms
Aconitate Hydratase, Aconitic Acid, Adolescent, Child, Child, Preschool, Female, Humans, Hydroxybutyrates, Isocitrates, Ketoglutaric Acids, Male, Phosphoenolpyruvate, Biomarkers, Heredodegenerative Disorders, Nervous System, Metabolomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review